Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/063160 stock hub

KRX/063160 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/063160is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

105.5B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/063160

In the news

Latest news · KRX/063160

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-16.3

P25 -17.1P50 0.7P75 8.5

ROIC-9.1

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/063160 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

KRW

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	519
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7063160006
Last refreshed	2026-05-10
Market cap	KRW 105.5B
Price	KRW 19,240
Price currency	KRW
Rev Per Employee	308,159,097.23x
Sector	Healthcare
Sic	2834
Symbol	krx/063160
Website	https://www.ckdbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-21.91%
FCF yield	-21.63%
P/B ratio	0.8x
P/S ratio	0.66x
PE Ratio10 Y	17.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-15.67%
EBITDA Margin	-4.63%
Gross margin	4.35%
Gross Profit	KRW 6.9B
Gross Profit Growth	-64.53%
Gross Profit Growth Q	-63.27%
Gross Profit Growth3 Y	-40.73%
Gross Profit Growth5 Y	-18.3%
Net Income	KRW -23.1B
Net Income Growth Years	0%
Pretax Margin	-16.75%
Profit Margin	-14.46%
Profit Per Employee	KRW -44.6M
ROA	-4.96
ROCE	-10.76
ROE	-16.26
ROIC	-9.07
Roic5y	1.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.41%
Cagr15y	2.58%
Cagr1y	-12.55%
Cagr20y	7.84%
Cagr3y	-9.81%
Cagr5y	-21.23%
Div CAGR10	0.49%
Div CAGR3	0%
Div CAGR5	-12.94%
EPS Growth Years	0
Revenue Growth	3.59x
Revenue Growth Q	12.64x
Revenue Growth Years	0x
Revenue Growth3 Y	5.61x
Revenue Growth5 Y	7.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.51
Assets	KRW 320.2B
Cash	KRW 12.3B
Current Assets	KRW 136.1B
Current Liabilities	KRW 87.3B
Debt	KRW 159.1B
Debt Equity	KRW 1.21
Debt FCF	KRW -6.97
Equity	KRW 131.6B
Interest Coverage	-5.49
Liabilities	KRW 188.6B
Long Term Assets	KRW 184.1B
Long Term Liabilities	KRW 101.3B
Net Cash	KRW -146.8B
Net Cash By Market Cap	KRW -139
Net Debt Equity	KRW 1.12
Tangible Book Value	KRW 125.7B
Tangible Book Value Per Share	KRW 22,914
WACC	4.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.56
Inventory Turnover	2.04
Net Working Capital	KRW 95.6B
Quick ratio	0.65
Working Capital	KRW 48.8B
Working Capital Turnover	KRW 3.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth Years	0%
Dividend per share	KRW 0
Dividend Years	1
Last Dividend	KRW 100

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-29.34%
1Y total return	-12.55%
200-day SMA	21,368.4
3Y total return	-26.65%
50-day SMA	19,478.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-69.68%
All Time High	119,000
All Time High Change	-83.83%
All Time High Date	2020-12-18
All Time Low	2,087.2
All Time Low Change	821.8%
All Time Low Date	2004-05-26
ATR	477.7
Beta	0.63
Beta1y	0.48
Beta2y	0.3
Ch YTD	-5.45
High	19,310
High52	27,650
High52 Date	2025-07-29
High52ch	-30.42%
Low	19,010
Low52	18,390
Low52 Date	2026-03-04
Low52ch	4.62%
Ma50ch	-1.23%
Price vs 200-day SMA	-9.96%
RSI	44.95
RSI Monthly	41.43
RSI Weekly	40.75
Sharpe ratio	-0.51x
Sortino ratio	-0.62
Total Return	0.02%
Tr YTD	-5.45
Tr15y	46.61%
Tr1m	4.17%
Tr1w	-1.33%
Tr3m	-7.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -25.1B
Operating margin	-15.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,337,770%
Net Borrowing	37,245,161,850
Shares Insiders	0.05%
Shares Out	5,485,960
Shares Qo Q	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -22.8B
Average Volume	42,315.3x
Bv Per Share	23,985.2
CAPEX	KRW -6.2B
Ch10y	-33.66
Ch15y	27.46
Ch1m	4.17
Ch1w	-1.33
Ch1y	-12.55
Ch20y	255.7
Ch3m	-7.5
Ch3y	-26.98
Ch5y	-69.89
Ch6m	-7.5
Change	-0.36%
Change From Open	-0.36
Close	19,310
Days Gap	0
Depreciation Amortization	17,660,951,000
Dollar Volume	301,856,360
EBIT	KRW -25.1B
EBITDA	KRW -7.4B
EPS	KRW -4,216
F Score	1
FCF	KRW -22.8B
FCF Per Share	KRW -4,162
Financing CF	37,245,161,760
Fiscal Year End	December
Founded	1,941
Income Tax	KRW -3.7B
Investing CF	-13,929,118,000
Is Primary Listing	1
Last Earnings Date	2025-08-14
Last Report Date	2023-09-30
Last Split Date	2019-12-27
Last Split Type	Forward
Ma150	20,717.5
Ma150ch	-7.13%
Ma20	19,537
Ma20ch	-1.52%
Net CF	6,701,758,280
Open	19,310
Payment Date	2025-04-07
Position In Range	76.67
Ppne	174,758,555,670
Price Date	2026-05-08
Ptbv Ratio	0.84
Relative Volume	0.37x
Revenue	159,934,571,460x
Tax By Revenue	-2.29x
Tr20y	352.79%
Tr6m	-7.5%
Volume	15,689
Z Score	1.23

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/063160 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/063160 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/063160?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/063160 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.9

Neutral momentum band

Price vs 200-day MA

-10.0%

50/200-day relationship not available

Beta (5Y)

0.63

Less volatile than the market

Sharpe ratio

-0.51

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/063160

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/063160 stock rating?

krx/063160 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/063160 analysis?

The full report lives at /stocks/krx/063160/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/063160?

The latest report frames krx/063160 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/063160 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.